July 28, 2014 5:44 AM ET

Biotechnology

Company Overview of Prolexys Pharmaceuticals, Inc.

Company Overview

Prolexys Pharmaceuticals, Inc., a biopharmaceutical company, discovers and exploits small molecule drugs to act at novel therapeutic targets in cancer and cardiovascular diseases. Its products include PRLX 93936, an anti-cancer therapeutic in a synthetic lethal screen against isogenic cell lines, engineered to differentially express various oncogenes, including wild type or oncogenic Ras; PRLX 8025 that reduces the cell proliferative activities of the beta catenin signaling pathway for the treatment of colon cancer; PRLX 43318, which emerged from phenotypic screens for targeting colon cancer cells; and HSP20 that signals transduction pathways leading to smooth muscle relaxation. Prolexys Pha...

2150 West Dauntless Avenue (1000 North)

Salt Lake City, UT 84116

United States

Founded in 2001

Phone:

801-303-1700

Fax:

801-303-1701

Key Executives for Prolexys Pharmaceuticals, Inc.

Scientific Founder
Age: 53
Director of Finance
Vice President of Drug Discovery Operations
Group Leader of DMPK and Discovery Analytical Sciences
Director of Cancer Pharmacology and Cell Biology
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Arcxis Biotechnologies, Inc. United States
Edwards Lifesciences Cardiovascular Resources Inc. United States
Endogeny Bio Corporation United States
SEDLine, Inc. United States
Synthetic Genomics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Prolexys Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.